TRIER PHARM ApS: Financial statements 2017
CVR: 31611083
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
TRIER PHARM ApS (CVR 31611083) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 481,250 and a net result of DKK 1,772 compared with DKK -599,533 the year before. That is a decrease of 2.6% compared with the year before. The profit margin was 0.4%. Equity in the 2017 report amounted to DKK -359,103.
- Revenue
- DKK 481,250
- Gross Profit
- DKK 20,384
- Profit/Loss
- DKK 1,772
- Equity
- DKK -359,103
- Total Assets
- DKK 397,819
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 481 t. | 20 t. | 2 t. | -359 t. | - |
| 2016 | 494 t. | 179 t. | -600 t. | -361 t. | - |
| 2015 | 594 t. | -209 t. | -232 t. | 239 t. | - |
| 2014 | 387 t. | -272 t. | -285 t. | 471 t. | - |
| 2013 | 261 t. | -17 t. | -21 t. | 756 t. | - |
Official annual report
Keep an eye on TRIER PHARM ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
TRIER PHARM ApS has published its annual report for 2016. Revenue came to DKK 494,000, and the net result was DKK -599,533.
About TRIER PHARM ApS
TRIER PHARM ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Klaus Trier. The company is owned by KLAUS TRIER HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -37,612 and a net result of DKK -67,143 compared with DKK -18,582 the year before. Equity in the 2025 report amounted to DKK -632,769.